Search

everythinglearnresearchcommunity

for

Search:↓

Tanshinone IIA helps protect tissue from low oxygen damage by activating certain cell pathways.

JAK inhibitors show promise in treating difficult skin diseases.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

DA-9401 helps protect rat testis from finasteride damage.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Gefitinib can cause rare scarring hair loss.

Combining TCA with 5-FU is more effective and safer for treating keloids than TCA alone.

Upadacitinib effectively treats pyoderma gangrenosum.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Finasteride effectively prevents biofilm formation and treats preformed biofilms, but requires high doses.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Oxiconazole nitrate cream is effective and safe for treating various fungal skin infections.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.